← Leaderboards
Jiwang Zhang
Loyola University Chicago
$6,063,199
Attributed
$6,063,199
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $710.4K · FY2010–25$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,063,199 · 6
By mechanism
R01$5,340,663 · 4
R21$722,536 · 2
Top collaborators
No co-investigators on record.
Most similar at Loyola University Chicago
Same institution · by research overlap
- Elizabeth J Kovacs$23,448,857
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMediatingSignal TransductionLeukemiaGrowthHematopoieticHematopoietic Stem CellsProteinsMutationInhibitor/AntagonistSelf-RenewalCytokineIn VitroMolecularPhenotypeCell LineBone MarrowDominant-Negative MutationLeukemic CellStem CellsKnock-OutPathway InteractionsProductionApoptosis
Grant awards (19)
Targeting PANoptotic pathways for Myelodysplastic Syndromes treatment$344,111
R01 · FY2025 · CA · contact PI
RIP1/RIP3-Calpain-Stat3 and NF-kappa B pathways in AML pathogenesis and treatment$332,738
R01 · FY2022 · CA · contact PI
RIP1/RIP3-Calpain-Stat3 and NF-kappa B pathways in AML pathogenesis and treatment$339,529
R01 · FY2021 · CA · contact PI
Systematic identification of hematopoietic stem cell expansion factors$370,877
R01 · FY2020 · HL · contact PI
RIP1/RIP3-Calpain-Stat3 and NF-kappa B pathways in AML pathogenesis and treatment$339,529
R01 · FY2020 · CA · contact PI
Systematic identification of hematopoietic stem cell expansion factors$370,877
R01 · FY2019 · HL · contact PI
RIP1/RIP3-Calpain-Stat3 and NF-kappa B pathways in AML pathogenesis and treatment$329,342
R01 · FY2019 · CA · contact PI
Systematic identification of hematopoietic stem cell expansion factors$370,877
R01 · FY2018 · HL · contact PI
RIP1/RIP3-Calpain-Stat3 and NF-kappa B pathways in AML pathogenesis and treatment$339,529
R01 · FY2018 · CA · contact PI
Systematic identification of hematopoietic stem cell expansion factors$370,877
R01 · FY2017 · HL · contact PI
Targeting alternative transcription/translation of RUNX1-ETO fusion gene$164,213
R21 · FY2016 · CA · contact PI
Targeting alternative transcription/translation of RUNX1-ETO fusion gene$197,055
R21 · FY2015 · CA · contact PI
Sensitize leukemia cells to differentiation by inhibiting necroptosis signal$164,213
R21 · FY2015 · CA · contact PI
The role of PTEN phosphorylation remodeling in hematopoietic stem cell regulation$362,612
R01 · FY2014 · HL · contact PI
Sensitize leukemia cells to differentiation by inhibiting necroptosis signal$197,055
R21 · FY2014 · CA · contact PI
The role of PTEN phosphorylation remodeling in hematopoietic stem cell regulation$352,252
R01 · FY2013 · HL · contact PI
The role of PTEN phosphorylation remodeling in hematopoietic stem cell regulation$370,013
R01 · FY2012 · HL · contact PI
The role of PTEN phosphorylation remodeling in hematopoietic stem cell regulation$373,750
R01 · FY2011 · HL · contact PI
The role of PTEN phosphorylation remodeling in hematopoietic stem cell regulation$373,750
R01 · FY2010 · HL · contact PI